Antimicrobial Resistance: A Growing Serious Threat for Global Public Health

Abstract

Antibiotics are among the most important discoveries of the 20th century, having saved millions of lives from infectious diseases. Microbes have developed acquired antimicrobial resistance (AMR) to many drugs due to high selection pressure from increasing use and misuse of antibiotics over the years. The transmission and acquisition of AMR occur primarily via a human–human interface both within and outside of healthcare facilities. A huge number of interdependent factors related to healthcare and agriculture govern the development of AMR through various drug-resistance mechanisms. The emergence and spread of AMR from the unrestricted use of antimicrobials in livestock feed has been a major contributing factor. The prevalence of antimicrobial-resistant bacteria has attained an incongruous level worldwide and threatens global public health as a silent pandemic, necessitating urgent intervention. Therapeutic options of infections caused by antimicrobial-resistant bacteria are limited, resulting in significant morbidity and mortality with high financial impact. The paucity in discovery and supply of new novel antimicrobials to treat life-threatening infections by resistant pathogens stands in sharp contrast to demand. Immediate interventions to contain AMR include surveillance and monitoring, minimizing over-the-counter antibiotics and antibiotics in food animals, access to quality and affordable medicines, vaccines and diagnostics, and enforcement of legislation. An orchestrated collaborative action within and between multiple national and international organizations is required urgently, otherwise, a postantibiotic era can be a more real possibility than an apocalyptic fantasy for the 21st century. This narrative review highlights on this basis, mechanisms and factors in microbial resistance, and key strategies to combat antimicrobial resistance.

Synthesis of Silver‐Doped Titanium Dioxide Nanoparticles by Sol‐Gel and Coprecipitation Techniques: Evaluation of Antimicrobial Activity and Cytotoxic Effects

“…[1,2] Microbes have developed acquired antimicrobial resistance (AMR) to many drugs due to high selection pressure from increasing use and misuse of antibiotics over the years. [3] Recently, nanoparticles (NPs) have drawn much attention because of their potential to be an alternative to antibiotics. [4] In contrast to traditional antibiotics, NPs combat microbes via multiple mechanisms that are simultaneously active.…”

Pillar[n]arenes in the Fight against Biofilms: Current Developments and Future Perspectives

“…Intensifying the intricacy of this situation is the worrisome trend of these bacteria developing resistance to well-established drugs and therapies . Drug resistance has presented a daunting challenge for healthcare practitioners, as this situation has led to the declining efficacy of treatments that were once considered most effective and reliable. , The need to confront these two intertwined challenges of surging infections and drug resistance has become a pressing priority in the field of public health. Biofilms, structured communities of microorganisms enveloped within the matrix of extracellular polymeric substances (EPSs), have surfaced as a ubiquitous and complex challenge with wide-ranging consequences. − Biofilms are very difficult to eliminate with antibiotics because the extracellular matrix safeguards bacteria from conventional antibiotics.…”

Antimicrobial and antibiofilm activity of human recombinant H1 histones against bacterial infections

“…Bacterial infections caused by multidrug-resistant bacteria are increasingly burdening the global healthcare system (1, 2). Bacteria have evolved various mechanisms to counteract the harmful effects of antibiotic molecules, including restriction drug uptake, upregulating efflux pumps, altering drug targets, and inactivating drugs (2). Additionally, bacteria have developed defense strategies at the multicellular level.…”